What does BioVeda Capital invest in?
BioVeda Capital invests most often at Series B and Series A (80% of the rounds on record), in sectors such as Biotechnology, SaaS and Biotechnology.

Singapore · Investor
No cheque observed since Mar 2013, after 5 earlier cheques, and the website is dead.
DormantGrowth equity
5 rounds on record
Mostly Series B and Series A: 80% of its rounds
Sole investor in 1 rounds, median $12M
1 exits from the portfolio
Every round we can evidence, newest first5 appearances
1 round
1 round
1 round
1 round
1 round
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
We hold 4 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
Companies it backed that were later bought or listed1 in all
An exit counts when it came after the firm's first round in the company. From historical deal records.
The investors most often in the same rounds as BioVeda Capital. A count of rooms they were both in, not a relationship either has claimed.
BioVeda Capital invests most often at Series B and Series A (80% of the rounds on record), in sectors such as Biotechnology, SaaS and Biotechnology.
5 investments on record, 0 of them in the last 12 months. The most recent was in Mar 2013.
The median round it joins is $11M.
Rarely, if at all: none of its 5 investments on record names it as the lead.
Most of the companies it backs are in Singapore (40%), the United States (40%) and the United Kingdom (20%).
It looks quiet: no investment on record since Mar 2013.
Most often Vertex Ventures China (2 rounds together).
BioVeda Capital is a growth equity firm based in Singapore, Singapore.
Find the investors who back rounds like yours, and keep every conversation on one fundraising board.
Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it